• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

作者信息

Monda Vincenzo M, Porcellati Francesca, Strollo Felice, Gentile Sandro

机构信息

Diabetes Unit "Santissima Annunziata" Hospital Cento, Ferrara, Italy.

Section of Internal Medicine, Endocrinology and Metabolism, Department of Medicine, Perugia University School of Medicine, Perugia, Italy.

出版信息

Diabetes Ther. 2020 Sep;11(9):1909-1914. doi: 10.1007/s13300-020-00898-8. Epub 2020 Aug 4.

DOI:10.1007/s13300-020-00898-8
PMID:32749644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7400747/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a224/7434825/5ae1000eba55/13300_2020_898_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a224/7434825/5ae1000eba55/13300_2020_898_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a224/7434825/5ae1000eba55/13300_2020_898_Fig1_HTML.jpg

相似文献

1
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?血管紧张素转换酶2与严重急性呼吸综合征冠状病毒2感染：胰高血糖素样肽-1受体激动剂可能发挥作用吗？
Diabetes Ther. 2020 Sep;11(9):1909-1914. doi: 10.1007/s13300-020-00898-8. Epub 2020 Aug 4.
2
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?糖尿病与新冠病毒肺炎中的二肽基肽酶4和血管紧张素转换酶2：心血管并发症的治疗靶点？
Front Pharmacol. 2020 Aug 7;11:1161. doi: 10.3389/fphar.2020.01161. eCollection 2020.
3
Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patients.新冠病毒肺炎患者鼻咽拭子和口咽拭子中SARS-CoV-2宿主入侵基因的表达谱
Heliyon. 2020 Oct;6(10):e05143. doi: 10.1016/j.heliyon.2020.e05143. Epub 2020 Oct 1.
4
COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?新型冠状病毒肺炎（COVID-19）：感染过程和糖尿病药物之间是否存在关联？
J Endocrinol Invest. 2020 Aug;43(8):1053-1060. doi: 10.1007/s40618-020-01318-1. Epub 2020 Jun 3.
5
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.糖尿病中糖化 ACE2 受体：SARS-COV-2 进入心肌细胞的门户。
Cardiovasc Diabetol. 2021 May 7;20(1):99. doi: 10.1186/s12933-021-01286-7.
6
Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors.分析 COVID-19 患者鼻咽拭子中的 miRNA hsa-let7b-5p 表达，支持其在调节 ACE2 和 DPP4 受体中的作用。
J Cell Mol Med. 2022 Oct;26(19):4940-4948. doi: 10.1111/jcmm.17492. Epub 2022 Sep 8.
7
Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance.将二甲双胍重新用于 2 型糖尿病伴胰岛素抵抗患者的新冠病毒并发症。
Immunopharmacol Immunotoxicol. 2021 Jun;43(3):265-270. doi: 10.1080/08923973.2021.1925294. Epub 2021 May 31.
8
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.ACE2 缺乏与 SARS-CoV-2 感染之间的关键联系。
Eur J Intern Med. 2020 Jun;76:14-20. doi: 10.1016/j.ejim.2020.04.037. Epub 2020 Apr 20.
9
Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections.西他列汀和利那列汀通过靶向 DPP4-RBD 相互作用为泛 SARS-CoV-2 感染提供了一种潜在的宿主导向治疗方法。
Int J Biol Macromol. 2023 Aug 1;245:125444. doi: 10.1016/j.ijbiomac.2023.125444. Epub 2023 Jun 27.
10
Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.血管紧张素转换酶 2 通过拮抗 I 型干扰素诱导及其下游信号通路增强 SARS-CoV-2 感染。
mSphere. 2022 Aug 31;7(4):e0021122. doi: 10.1128/msphere.00211-22. Epub 2022 Jul 12.

引用本文的文献

1
Cross-relationship between COVID-19 infection and anti-obesity products efficacy and incidence of side effects: A cross-sectional study.新型冠状病毒感染与抗肥胖产品疗效及副作用发生率的交叉关系：一项横断面研究。
PLoS One. 2024 Aug 22;19(8):e0309323. doi: 10.1371/journal.pone.0309323. eCollection 2024.
2
The impact of preadmission/prediagnosis use of GLP-1 receptor agonists on COVID-19 mortality in patients with diabetes: A systematic review and meta-analysis.入院前/诊断前使用胰高血糖素样肽-1受体激动剂对糖尿病患者新冠病毒疾病死亡率的影响：一项系统评价和荟萃分析
Health Sci Rep. 2023 Sep 13;6(9):e1549. doi: 10.1002/hsr2.1549. eCollection 2023 Sep.
3

本文引用的文献

1
Letter to the editor: Comment on GLP-1-based drugs and COVID-19 treatment.致编辑的信：关于基于胰高血糖素样肽-1（GLP-1）的药物与新冠病毒病治疗的评论
Acta Pharm Sin B. 2020 Jul;10(7):1249-1250. doi: 10.1016/j.apsb.2020.05.006. Epub 2020 May 26.
2
Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis.新型抗糖尿病药物在 COVID-19 危机期间的潜在益处和危害。
Int J Environ Res Public Health. 2020 May 22;17(10):3664. doi: 10.3390/ijerph17103664.
3
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
The Impact of GLP-1 RAs and DPP-4is on Hospitalisation and Mortality in the COVID-19 Era: A Two-Year Observational Study.
胰高血糖素样肽-1受体激动剂和二肽基肽酶-4抑制剂对新冠疫情时代住院率和死亡率的影响：一项为期两年的观察性研究
Biomedicines. 2023 Aug 18;11(8):2292. doi: 10.3390/biomedicines11082292.
4
Blood pH Analysis in Combination with Molecular Medical Tools in Relation to COVID-19 Symptoms.结合分子医学工具对与COVID-19症状相关的血液pH值分析
Biomedicines. 2023 May 11;11(5):1421. doi: 10.3390/biomedicines11051421.
5
Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches.探索西格列汀治疗 2 型糖尿病的新靶点：网络药理学、分子对接、分子动力学模拟和 SPR 方法。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1096655. doi: 10.3389/fendo.2022.1096655. eCollection 2022.
6
The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-Therapeutic potential exploration in lung injury.胰高血糖素样肽-1的抗炎特性及其相关糖尿病药物——肺损伤治疗潜力的探索
Acta Pharm Sin B. 2022 Nov;12(11):4040-4055. doi: 10.1016/j.apsb.2022.06.003. Epub 2022 Jun 11.
7
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression.降糖素样肽-1 受体激动剂（GLP-1RA）与 2019 年冠状病毒病（COVID-19）死亡率的相关性：系统评价、荟萃分析和荟萃回归。
Diabetes Res Clin Pract. 2021 Sep;179:109031. doi: 10.1016/j.diabres.2021.109031. Epub 2021 Aug 28.
8
The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism.胰高血糖素样肽-1受体激动剂在新冠疫情期间的作用：一种假设的分子机制。
Expert Opin Drug Saf. 2021 Nov;20(11):1309-1315. doi: 10.1080/14740338.2021.1970744. Epub 2021 Aug 25.
9
Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection.新型冠状病毒感染合并 2 型糖尿病患者的治疗。
Int J Mol Sci. 2021 Jul 16;22(14):7605. doi: 10.3390/ijms22147605.
10
Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.胰高血糖素样肽 1 受体激动剂和钠-葡萄糖共转运蛋白 2 抑制剂的使用与 COVID-19 结局的关联。
Diabetes Care. 2021 Jul;44(7):1564-1572. doi: 10.2337/dc21-0065. Epub 2021 Jun 16.
严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
4
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.ACE2 缺乏与 SARS-CoV-2 感染之间的关键联系。
Eur J Intern Med. 2020 Jun;76:14-20. doi: 10.1016/j.ejim.2020.04.037. Epub 2020 Apr 20.
5
Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.冠状病毒感染与 2 型糖尿病：具有治疗意义的共同途径。
Endocr Rev. 2020 Jun 1;41(3). doi: 10.1210/endrev/bnaa011.
6
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.血管紧张素转换酶 2：SARS-CoV-2 受体和肾素-血管紧张素系统的调节剂：庆祝 ACE2 发现 20 周年。
Circ Res. 2020 May 8;126(10):1456-1474. doi: 10.1161/CIRCRESAHA.120.317015. Epub 2020 Apr 8.
7
COVID-19 and diabetes: Can DPP4 inhibition play a role?2019冠状病毒病与糖尿病：二肽基肽酶4抑制作用能否发挥作用？
Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
8
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.血管紧张素受体阻滞剂可作为治疗 SARS-CoV-2 的候选药物。
Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
9
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.血管紧张素转换酶2（ACE2）作为严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的受体：分子机制与潜在治疗靶点
Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.
10
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.新冠病毒的基因组特征和流行病学：对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.